Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3051 | 1939 | 35.0 | 67% |
Classes in level above (level 3) |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DT DIAPHORASE | Author keyword | 97 | 54% | 6% | 125 |
2 | EO9 | Author keyword | 64 | 86% | 2% | 32 |
3 | NQO1 | Author keyword | 54 | 36% | 6% | 123 |
4 | KW 2149 | Author keyword | 49 | 94% | 1% | 17 |
5 | RH1 | Author keyword | 23 | 79% | 1% | 15 |
6 | MITOSENE | Author keyword | 21 | 90% | 0% | 9 |
7 | NQO1 POLYMORPHISM | Author keyword | 14 | 100% | 0% | 7 |
8 | NQO2 | Author keyword | 11 | 56% | 1% | 14 |
9 | FK317 | Author keyword | 11 | 100% | 0% | 6 |
10 | INDOLEQUINONE | Author keyword | 11 | 69% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DT DIAPHORASE | 97 | 54% | 6% | 125 | Search DT+DIAPHORASE | Search DT+DIAPHORASE |
2 | EO9 | 64 | 86% | 2% | 32 | Search EO9 | Search EO9 |
3 | NQO1 | 54 | 36% | 6% | 123 | Search NQO1 | Search NQO1 |
4 | KW 2149 | 49 | 94% | 1% | 17 | Search KW+2149 | Search KW+2149 |
5 | RH1 | 23 | 79% | 1% | 15 | Search RH1 | Search RH1 |
6 | MITOSENE | 21 | 90% | 0% | 9 | Search MITOSENE | Search MITOSENE |
7 | NQO1 POLYMORPHISM | 14 | 100% | 0% | 7 | Search NQO1+POLYMORPHISM | Search NQO1+POLYMORPHISM |
8 | NQO2 | 11 | 56% | 1% | 14 | Search NQO2 | Search NQO2 |
9 | FK317 | 11 | 100% | 0% | 6 | Search FK317 | Search FK317 |
10 | INDOLEQUINONE | 11 | 69% | 0% | 9 | Search INDOLEQUINONE | Search INDOLEQUINONE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DT DIAPHORASE | 211 | 39% | 22% | 422 |
2 | DT DIAPHORASE ACTIVITY | 88 | 71% | 4% | 72 |
3 | FR 900482 | 61 | 77% | 2% | 41 |
4 | QUINONE OXIDOREDUCTASE 1 | 55 | 66% | 3% | 51 |
5 | BIOREDUCTIVE ACTIVATION | 53 | 70% | 2% | 44 |
6 | C609T POLYMORPHISM | 53 | 89% | 1% | 24 |
7 | NADPH QUINONE OXIDOREDUCTASE | 51 | 38% | 6% | 108 |
8 | ANTITUMOR QUINONES | 46 | 70% | 2% | 39 |
9 | AZIRIDINYLBENZOQUINONES | 40 | 76% | 1% | 28 |
10 | PORFIROMYCIN | 35 | 76% | 1% | 25 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones | 2012 | 53 | 108 | 63% |
Mitomycinoid Alkaloids: Mechanism of Action, Biosynthesis, Total Syntheses, and Synthetic Approaches | 2013 | 16 | 254 | 72% |
NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector | 2010 | 142 | 98 | 35% |
NAD(P)H : quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms | 2000 | 320 | 129 | 58% |
MITOMYCIN-C - SMALL, FAST AND DEADLY (BUT VERY SELECTIVE) | 1995 | 224 | 25 | 80% |
ANTIOXIDANT AND PROOXIDANT FUNCTIONS OF DT-DIAPHORASE IN QUINONE METABOLISM | 1995 | 219 | 120 | 70% |
EO9 (Apaziquone): from the clinic to the laboratory and back again | 2013 | 10 | 72 | 65% |
NAD(P)H : Quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenctics | 2004 | 134 | 129 | 60% |
DT-DIAPHORASE IN ACTIVATION AND DETOXIFICATION OF QUINONES - BIOREDUCTIVE ACTIVATION OF MITOMYCIN-C | 1993 | 143 | 59 | 80% |
Quinone reductases multitasking in the metabolic world | 2004 | 99 | 90 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED ONCOL CRC | 2 | 67% | 0.1% | 2 |
2 | GRP EXPT RADIAT ONCOL | 1 | 100% | 0.1% | 2 |
3 | THER EUT RADIOL DEV THER EUT PROGRAM | 1 | 100% | 0.1% | 2 |
4 | TOM CONNORS CANC | 1 | 14% | 0.4% | 7 |
5 | ANALYT PHARM | 1 | 50% | 0.1% | 1 |
6 | BIOTECHNOL PHARMACOL MOL CELLULAIRE | 1 | 50% | 0.1% | 1 |
7 | CATHARIJNESINGEL 60 | 1 | 50% | 0.1% | 1 |
8 | CHEM MOL BIOL MED CHEM | 1 | 50% | 0.1% | 1 |
9 | COMPLEMENTARY ALTERNAT MED RD | 1 | 50% | 0.1% | 1 |
10 | DENTISTRY PHARM | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000027912 | PHENOXODIOL//DIARYLSULFONYLUREA//TNOX |
2 | 0.0000023822 | SHIKONIN//BETA LAPACHONE//PLUMBAGIN |
3 | 0.0000019620 | BNCT//BORON NEUTRON CAPTURE THERAPY//TIRAPAZAMINE |
4 | 0.0000016361 | VITAMIN K//PHYLLOQUINONE//VITAMIN K2 |
5 | 0.0000016054 | SULFORAPHANE//GLUCOSINOLATES//NRF2 |
6 | 0.0000015614 | GSTM1//GSTT1//GLUTATHIONE S TRANSFERASE |
7 | 0.0000014947 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN |
8 | 0.0000012486 | DUOCARMYCINS//PYRROLOBENZODIAZEPINE//PYRROLE IMIDAZOLE POLYAMIDE |
9 | 0.0000008763 | ORTHO PHENYLPHENOL//SEX DISCRIMINATION OF CANCER RISK//HEPATOCARCINOGENESIS |
10 | 0.0000008428 | REISSERT COMPOUNDS//O BETA D GLUCOSIDES//POM ANALYSES |